These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37213711)

  • 41. Genetics of Parkinson's disease in Brazil: a systematic review of monogenic forms.
    Santos-Lobato BL; Schumacher-Schuh A; Mata IF; Letro GH; Braga-Neto P; Brandão PRP; Godeiro-Junior CO; Coletta MVD; Camargos ST; Borges V; Rieder CRM; Tumas V
    Arq Neuropsiquiatr; 2021 Jul; 79(7):612-623. PubMed ID: 34468500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.
    Bandres-Ciga S; Faghri F; Majounie E; Koretsky MJ; Kim J; Levine KS; Leonard H; Makarious MB; Iwaki H; Crea PW; Hernandez DG; Arepalli S; Billingsley K; Lohmann K; Klein C; Lubbe SJ; Jabbari E; Saffie-Awad P; Narendra D; Reyes-Palomares A; Quinn JP; Schulte C; Morris HR; Traynor BJ; Scholz SW; Houlden H; Hardy J; Dumanis S; Riley E; Blauwendraat C; Singleton A; Nalls M; Jeff J; Vitale D
    medRxiv; 2023 Nov; ():. PubMed ID: 37986980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature.
    Jonson C; Levine KS; Lake J; Hertslet L; Jones L; Patel D; Kim J; Bandres-Ciga S; Terry N; Mata IF; Blauwendraat C; Singleton AB; Nalls MA; Yokoyama JS; Leonard HL
    medRxiv; 2024 Jan; ():. PubMed ID: 38260595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding monogenic Parkinson's disease at a global scale.
    Junker J; Lange LM; Vollstedt EJ; Roopnarain K; Doquenia MLM; Annuar AA; Avenali M; Bardien S; Bahr N; Ellis M; Galandra C; Gasser T; Heutink P; Illarionova A; Kanana Y; Keller Sarmiento IJ; Kumar KR; Lim SY; Madoev H; Mata IF; Mencacci NE; Nalls MA; Padmanabhan S; Shambetova C; Solle J; Tan AH; Trinh J; Valente EM; Singleton A; Blauwendraat C; Lohmann K; Fang ZH; Klein C;
    medRxiv; 2024 Apr; ():. PubMed ID: 38529492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancing Personalized Medicine in Common Forms of Parkinson's Disease through Genetics: Current Therapeutics and the Future of Individualized Management.
    Reed X; Schumacher-Schuh A; Hu J; Bandres-Ciga S
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33804504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parkinson's disease diagnosis using deep learning: A bibliometric analysis and literature review.
    Abumalloh RA; Nilashi M; Samad S; Ahmadi H; Alghamdi A; Alrizq M; Alyami S
    Ageing Res Rev; 2024 Apr; 96():102285. PubMed ID: 38554785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RIC3 variants are not associated with Parkinson's disease in large European, Latin American, or East Asian cohorts.
    Brolin K; Bandres-Ciga S; Leonard H; Makarious MB; Blauwendraat C; Mata IF; Foo JN; Pihlstrøm L; Swanberg M; Gan-Or Z; Tan MM;
    Neurobiol Aging; 2022 Jan; 109():264-268. PubMed ID: 34538707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global biomarker trends in Parkinson's disease research: A bibliometric analysis.
    Wang X; Dong T; Li X; Yu W; Jia Z; Liu Y; Yang J
    Heliyon; 2024 Mar; 10(6):e27437. PubMed ID: 38501016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantifying Dynamic Balance in Young, Elderly and Parkinson's Individuals: A Systematic Review.
    Siragy T; Nantel J
    Front Aging Neurosci; 2018; 10():387. PubMed ID: 30524270
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis.
    Li T; Zou S; Zhang Z; Liu M; Liang Z
    BMC Neurol; 2022 Aug; 22(1):320. PubMed ID: 36008796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
    Fernández-Santiago R; Sharma M
    Ageing Res Rev; 2022 Aug; 79():101648. PubMed ID: 35595184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The genetics of Parkinson's disease.
    Mullin S; Schapira A
    Br Med Bull; 2015 Jun; 114(1):39-52. PubMed ID: 25995343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson's disease.
    Kõks S; Pfaff AL; Singleton LM; Bubb VJ; Quinn JP
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1680-1690. PubMed ID: 36000172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moving the Dial Toward Equity in Parkinson's Disease Clinical Research: a Review of Current Literature and Future Directions in Diversifying PD Clinical Trial Participation.
    Adrissi J; Fleisher J
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):475-483. PubMed ID: 35713775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genetic background of Parkinson's disease: current progress and future prospects.
    Kalinderi K; Bostantjopoulou S; Fidani L
    Acta Neurol Scand; 2016 Nov; 134(5):314-326. PubMed ID: 26869347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MEX-PD: A National Network for the Epidemiological & Genetic Research of Parkinson's Disease.
    Lázaro-Figueroa A; Reyes-Pérez P; Morelos-Figaredo E; Guerra-Galicia CM; Estrada-Bellmann I; Salinas-Barboza K; Matuk-Pérez Y; Gandarilla-Martínez NA; Caballero-Sánchez U; Flores-Ocampo V; Montés-Alcántara P; Espinosa-Méndez IM; Moral AZ; Gaspar-Martínez E; Vazquez-Guevara D; Rodríguez-Violante M; Inca-Martinez M; Mata IF; Alcauter S; Rentería ME; Medina-Rivera A; Ruiz-Contreras AE
    medRxiv; 2023 Aug; ():. PubMed ID: 37693616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.